Suchergebnisse - "Latagliata, Roberto"

PubPharm (396)

1

Safety and Efficacy of TKIs in Very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia

enthalten in: Preprints.org | 2024

von Costa, A. | Abruzzese, E. | Latagliata, R. | +8

2

Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia

enthalten in: Journal of clinical medicine | 2024

von Costa, A. | Abruzzese, E. | Latagliata, R. | +8

3

Pulmonary infections in patients with acute myeloid leukemia receiving frontline treatment with hypomethylating agents

enthalten in: Leukemia & lymphoma | 2023

von Scamuffa, M. | Latagliata, R. | Carmosino, I. | +9

4

Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes : correlations with morphology and mutational profile

enthalten in: Annals of hematology | 2023

von Guarnera, L. | Fabiani, E. | Attrotto, C. | +9

5

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia : Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Oliva, E. | Riva, M. | Niscola, P. | +39

CommentIn: J Clin Oncol. 2023 Oct 1;41(28):4465-4468. - PMID 37428990

6

Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia : A study from the Registro Italiano LMC and Campus CML

enthalten in: Cancer | 2023

von Tiribelli, M. | Latagliata, R. | Breccia, M. | +38

7

Treatment in patients with acute myeloid leukemia/high-risk myelodysplastic syndrome with hypomethylating agents : Day-hospital management compared to home care setting

enthalten in: European journal of haematology | 2023

von Trapè, G. | De Angelis, G. | Morucci, M. | +22

8

Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile

enthalten in: Annals of hematology | 2023

von Guarnera, L. | Fabiani, E. | Attrotto, C. | +9

9

Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients : A Real-World PV-NET Study

enthalten in: Cancers | 2023

von Palandri, F. | Rossi, E. | Auteri, G. | +34

10

Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials

enthalten in: Annals of hematology | 2023

von Luciano, L. | Latagliata, R. | Gugliotta, G. | +18

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[40]